Data-driven insights into the future market dynamics for nearly 40 tumors.

With a forward-looking focus on the clinical landscape,  SMARTOncology Tumor Insights – a syndicated report- is the best way to understand your market opportunity, access detailed clinical data, and receive updates on the changing landscape.

Oncology is the cornerstone of SmartAnalyst’s consulting business, and we have developed the series as a foundation for our clients’ key clinical and commercial development and BD&L decision.

With the SMARTOncology Tumor Insights, you will:

  • Obtain a forward-looking perspective and expert views on key tumors, in order to shape commercial and clinical decisions for pipeline assets and BD opportunities
  • Stay current, with updates delivered twice each year
  • Understand how the competitive dynamics would impact the treatment paradigm in the coming 2-3 years
  • Acquire comprehensive foundational data with rich clinical data and insights
  • Keep track of the immunotherapy landscape and its impact on strategic decisions on an IO/non-IO in the portfolio
  • Get a global perspective, with insights on the US, EU, and select Asia-Pacific* markets
  • Consolidate key insights and data in one concise report – and avoid internal “fire drills” accessing data
  • Quickly get up to speed on a tumor when evaluating a BD&L opportunity
  • Easily cut-and-paste data and slides into your own presentations

2021 Planner/Available Now

  • Solid Tumors
    • Bladder Cancer
    • Cervical Cancer
    • Colorectal Cancer
    • DTC
    • Endometrial
    • Esophageal Cancer
    • Gastric Cancer
    • GBM
    • Glioma
    • HCC
    • HER2+ Breast Cancer
    • HER2NegHR+ Breast Cancer
    • Melanoma
    • Mesothelioma
    • MTC
    • NET
    • NSCLC
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate
    • RCC
    • SCCHN
    • SCLC
    • TNBC
  • Hematologic Malignancies
    • ALL
    • AML
    • CLL
    • Diffuse-large B-cell Lymphoma
    • Follicular Lymphoma
    • HL
    • MZL
    • MCL
    • MDS
    • Multiple Myeloma
    • Myelofibrosis
    • Primary CNS Lymphoma
    • SLL
    • Waldenström Macroglobulinemia
  • View Sample

Updates available after major conferences – ASCO, ASCO GI, ASCO GU, AACR, ASH, EHA, ESMO, and SABCS

Additional tumors can be covered or we can customize reports, as required.

SMARTOncology Tumor Insights – Table of Contents: